Leon Cooperman: Why He Got Out of Valeant Long Before Crash

Omega Advisors CEO had much to say about the company's breakdown

Author's Avatar
Mar 15, 2016
Article's Main Image


Valeant Pharmaceuticals (VRX, Financial) stock plunged by more than 50% Tuesday after it revised down guidance and mentioned a possible debt default. The company split major investors, as some exited due to surfacing of questionable practices, and some retaining their holdings or even adding to them on a recent dip. Leon Cooperman (Trades, Portfolio) was one of the ones who dropped the company and discussed the reasons for the company's trouble on CNBC this afternoon: